Length-41 minutes, 5 seconds
Deborah Harper, President of Psychjourney, interviews Dr. David Tolin, co-author of Buried in Treasures: Help for Compulsive Acquiring, Saving, and Hoarding (with Drs. R. Frost and G. Steketee published by Oxford University Press.
David Tolin, Ph.D.
Dr. Tolin is the founder and Director of the Anxiety Disorders Center at The Institute of Living. He is also Assistant Professor of Psychiatry at the University of Connecticut School of Medicine. Dr. Tolin received his Ph.D. from the University of Arkansas, and completed a predoctoral internship at Tufts University School of Medicine/VA Medical Center, Boston.
Dr. Tolin’s research and clinical interests include cognitive-behavioral therapy for anxiety disorders in adults and children, and cognitive processes that underlie anxiety disorders, particularly obsessive-compulsive disorder, posttraumatic stress disorder, and panic disorder. He is the recipient of the award for Distinguished Contribution to the Science of Psychology from the Connecticut Psychological Association, and an Early Career Award from the Anxiety Disorders Special Interest Group of the Association for Advancement of Behavior Therapy. He is a Fellow of the Council for Scientific Medicine and Mental Health.
Dr. Tolin is the author of over 90 journal articles and book chapters, and over 140 research presentations to national and international organizations. He is co-author of Buried in Treasures: Help for Compulsive Acquiring, Saving, and Hoarding (with Drs. R. Frost and G. Steketee) and Trichotillomania: Cognitive Behavior Therapy for Hair Pulling and Related Problems (with Dr. M. Franklin).
Dr. Tolin is principal investigator on the National Institute of Mental Health (NIMH)-funded studies “Stepped Care for Obsessive-Compulsive Disorder” and “Neural Mechanisms of Compulsive Hoarding,” and co-investigator on the NIMH-funded studies “Psychopathology of Compulsive Hoarding” (principal investigator: R. Frost), “Treatment of Compulsive Hoarding” (principal investigator: G. Steketee), and “Screening for GAD among Frail Elderly” (principal investigator: G. Diefenbach). He has served as principal investigator on several industry-sponsored clinical trials of experimental medications. Visit his website.

Recent Comments